Cargando…
Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents
Targeting neovessels in chronic tendinopathies has emerged as a new therapeutic approach and several embolization agents have been reported. The aim of this study was to investigate the feasibility of embolization with different agents in a porcine model of patellar tendinopathy and evaluate their s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501590/ https://www.ncbi.nlm.nih.gov/pubmed/36143314 http://dx.doi.org/10.3390/jpm12091530 |
_version_ | 1784795512405229568 |
---|---|
author | Ghelfi, Julien Soulairol, Ian Stephanov, Olivier Bacle, Marylène de Forges, Hélène Sanchez-Ballester, Noelia Ferretti, Gilbert Beregi, Jean-Paul Frandon, Julien |
author_facet | Ghelfi, Julien Soulairol, Ian Stephanov, Olivier Bacle, Marylène de Forges, Hélène Sanchez-Ballester, Noelia Ferretti, Gilbert Beregi, Jean-Paul Frandon, Julien |
author_sort | Ghelfi, Julien |
collection | PubMed |
description | Targeting neovessels in chronic tendinopathies has emerged as a new therapeutic approach and several embolization agents have been reported. The aim of this study was to investigate the feasibility of embolization with different agents in a porcine model of patellar tendinopathy and evaluate their safety and efficacy. Eight 3-month-old male piglets underwent percutaneous injection of collagenase type I to induce patellar tendinopathies (n = 16 tendons). They were divided into four groups (2 piglets, 4 tendons/group): the control group, 50–100 µm microspheres group, 100–300 µm microspheres group, and the Imipenem/Cilastatin (IMP/CS) group. Angiography and embolization were performed for each patellar tendon on day 7 (D7). The neovessels were evaluated visually with an angiography on day 14. The pathological analysis assessed the efficacy (Bonar score, number of neovessels/mm(2)) and safety (off-target persistent cutaneous ischemic modifications and presence of off-target embolization agents). The technical success was 92%, with a failed embolization for one tendon due to an arterial dissection. Neoangiogenesis was significantly less important in the embolized groups compared to the control group angiographies (p = 0.04) but not with respect to histology (Bonar score p = 0.15, neovessels p = 0.07). Off-target cutaneous embolization was more frequently depicted in the histology of the 50–100 µm microspheres group (p = 0.02). Embolization of this animal model with induced patellar tendinopathy was technically feasible with different agents and allowed assessing the safety and efficacy of neovessel destruction. Particles smaller than 100 µm seemed to be associated with more complications. |
format | Online Article Text |
id | pubmed-9501590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95015902022-09-24 Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents Ghelfi, Julien Soulairol, Ian Stephanov, Olivier Bacle, Marylène de Forges, Hélène Sanchez-Ballester, Noelia Ferretti, Gilbert Beregi, Jean-Paul Frandon, Julien J Pers Med Article Targeting neovessels in chronic tendinopathies has emerged as a new therapeutic approach and several embolization agents have been reported. The aim of this study was to investigate the feasibility of embolization with different agents in a porcine model of patellar tendinopathy and evaluate their safety and efficacy. Eight 3-month-old male piglets underwent percutaneous injection of collagenase type I to induce patellar tendinopathies (n = 16 tendons). They were divided into four groups (2 piglets, 4 tendons/group): the control group, 50–100 µm microspheres group, 100–300 µm microspheres group, and the Imipenem/Cilastatin (IMP/CS) group. Angiography and embolization were performed for each patellar tendon on day 7 (D7). The neovessels were evaluated visually with an angiography on day 14. The pathological analysis assessed the efficacy (Bonar score, number of neovessels/mm(2)) and safety (off-target persistent cutaneous ischemic modifications and presence of off-target embolization agents). The technical success was 92%, with a failed embolization for one tendon due to an arterial dissection. Neoangiogenesis was significantly less important in the embolized groups compared to the control group angiographies (p = 0.04) but not with respect to histology (Bonar score p = 0.15, neovessels p = 0.07). Off-target cutaneous embolization was more frequently depicted in the histology of the 50–100 µm microspheres group (p = 0.02). Embolization of this animal model with induced patellar tendinopathy was technically feasible with different agents and allowed assessing the safety and efficacy of neovessel destruction. Particles smaller than 100 µm seemed to be associated with more complications. MDPI 2022-09-18 /pmc/articles/PMC9501590/ /pubmed/36143314 http://dx.doi.org/10.3390/jpm12091530 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ghelfi, Julien Soulairol, Ian Stephanov, Olivier Bacle, Marylène de Forges, Hélène Sanchez-Ballester, Noelia Ferretti, Gilbert Beregi, Jean-Paul Frandon, Julien Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents |
title | Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents |
title_full | Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents |
title_fullStr | Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents |
title_full_unstemmed | Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents |
title_short | Feasibility of Neovessel Embolization in a Large Animal Model of Tendinopathy: Safety and Efficacy of Various Embolization Agents |
title_sort | feasibility of neovessel embolization in a large animal model of tendinopathy: safety and efficacy of various embolization agents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501590/ https://www.ncbi.nlm.nih.gov/pubmed/36143314 http://dx.doi.org/10.3390/jpm12091530 |
work_keys_str_mv | AT ghelfijulien feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT soulairolian feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT stephanovolivier feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT baclemarylene feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT deforgeshelene feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT sanchezballesternoelia feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT ferrettigilbert feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT beregijeanpaul feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents AT frandonjulien feasibilityofneovesselembolizationinalargeanimalmodeloftendinopathysafetyandefficacyofvariousembolizationagents |